title: Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease.
authors.forename: Pál
authors.initials: P
authors.lastname: Miheller
authors.forename: Györgyi
authors.initials: G
authors.lastname: Muzes
authors.forename: Gábor
authors.initials: G
authors.lastname: Lakatos
authors.forename: Emese
authors.initials: E
authors.lastname: Mihály
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Tulassay
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced* / Q000276:immunology; D000069285:Infliximab; D008297:Male; D012713:Serum Sickness / Q000139:chemically induced* / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab